Improving the inpatient diagnostic management to reduce hospitalization time, diagnostic analysis requests and therapeutic treatments see more

THE RAPID ANALYSIS OF HUMAN BIOLOGICAL LIQUIDS IS DECISIVE TO THE INPATIENT FOR WHOM THE TIMELY CORRECT DIAGNOSIS AND THE BEGINNING OF AN ADEQUATE THERAPY IN MOST CASES REPRESENT THE ONLY WAY TO SURVIVE.

In addition to community acquired infections, hospital acquired infections have a high Public Health impact by increasing morbidity and mortality rates and costs through prolonged hospital stays and additional diagnostic and treatment costs.

Using the patented technology based on light scattering Alfred 60 
and HB&L are able to monitor the intense bacteria replication activity 
from the inoculum step into specific culture broths providing real 
time growth curves. s
Quantitative bacterial count results are reported in CFU/ml.
Due to the optimization of the broth it is possible to perform the 
bacterial culture in sterile and non sterile endocavitary samples 
such as respiratory fluids, cerebrospinal fluid and pleural fluid 
offering a sensitivity of 1 CFU/ml in 6 hours.
Enhanced liquid culture media combined with a specific supplement 
(DEB) has been developed to detect aerobic bacteria and exigent 
micro-organisms such as Haemophilus influenza, Neisseria meningitides
as well as samples characterized by extremely low bacterial counts.
Only live bacteria are detected while interference from non replicating
substances such as erythrocytes, leucocytes, dead cells and salts present
in the sample are eliminated during the initial zero reading.